Nuveen Asset Management, LLC Igm Biosciences, Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 45,015 shares of IGMS stock, worth $310,603. This represents 0.0% of its overall portfolio holdings.

Number of Shares

45,015

Previous 40,749 10.47%

Holding current value

$310,603

Previous $279,000 166.67%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$6.28 - $17.68 $26,790 - $75,422	4,266 Added 10.47%	45,015 $744,000
Q1 2024 May 13, 2024	SELL	$8.68 - $17.36 $78,762 - $157,524	-9,074 Reduced 18.21%	40,749 $393,000
Q4 2023 Feb 14, 2024	SELL	$3.94 - $8.79 $115,694 - $258,109	-29,364 Reduced 37.08%	49,823 $414,000
Q2 2023 Aug 14, 2023	SELL	$8.86 - $14.0 $17,560 - $27,748	-1,982 Reduced 2.44%	79,187 $730,000
Q1 2023 May 15, 2023	SELL	$13.74 - $25.76 $26,586 - $49,845	-1,935 Reduced 2.33%	81,169 $1.12 Million
Q4 2022 Feb 14, 2023	BUY	$15.45 - $26.02 $585,864 - $986,678	37,920 Added 83.92%	83,104 $1.41 Million
Q3 2022 Nov 14, 2022	SELL	$15.42 - $27.01 $655,427 - $1.15 Million	-42,505 Reduced 48.47%	45,184 $1.03 Million
Q2 2022 Aug 15, 2022	BUY	$13.27 - $25.5 $813,145 - $1.56 Million	61,277 Added 232.0%	87,689 $1.58 Million
Q1 2022 May 16, 2022	BUY	$13.42 - $29.73 $33,952 - $75,216	2,530 Added 10.59%	26,412 $420,000
Q4 2021 Feb 14, 2022	SELL	$27.59 - $66.39 $195,171 - $469,642	-7,074 Reduced 22.85%	23,882 $700,000
Q3 2021 Nov 12, 2021	SELL	$65.76 - $90.65 $568,889 - $784,213	-8,651 Reduced 21.84%	30,956 $2.04 Million
Q2 2021 Aug 16, 2021	BUY	$57.98 - $96.6 $391,191 - $651,760	6,747 Added 20.53%	39,607 $3.3 Million
Q1 2021 May 17, 2021	BUY	$71.56 - $121.23 $231,138 - $391,572	3,230 Added 10.9%	32,860 $2.52 Million
Q4 2020 May 17, 2021	SELL	$47.41 - $115.03 $171,434 - $415,948	-3,616 Reduced 10.88%	29,630 $2.62 Million
Q4 2020 Feb 16, 2021	SELL	$47.41 - $115.03 $882,157 - $2.14 Million	-18,607 Reduced 35.88%	33,246 $2.94 Million
Q3 2020 Nov 16, 2020	SELL	$43.0 - $84.01 $115,799 - $226,238	-2,693 Reduced 4.94%	51,853 $3.83 Million
Q2 2020 Aug 14, 2020	BUY	$51.3 - $75.21 $1.81 Million - $2.66 Million	35,350 Added 184.15%	54,546 $3.98 Million
Q1 2020 May 14, 2020	BUY	$31.51 - $73.75 $358,520 - $839,127	11,378 Added 145.54%	19,196 $1.08 Million
Q4 2019 Feb 14, 2020	BUY	$17.25 - $49.51 $134,860 - $387,069	7,818 New	7,818 $298,000

Others Institutions Holding IGMS

# of Institutions

Shares Held

20.7M

Call Options Held

68K

Put Options Held

52.2K

View Full List

About IGM Biosciences, Inc.

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $200M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

More about IGMS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Igm Biosciences, Inc. Transaction History